1. Alaba, O., and Bernstein, I., 1978, Tumor-growth suppression in vivo: Cooperation between immune lymphoid cells sensitized in vitro and nonimmune bone marrow cells, J. Immunol.
120:1941–1946.
2. Andrus, L., Atkinson, K., and Lafferty, K. J., 1982, Lethal effect of the intravenous injection of H-2 alloantigen-activated T cells, Clin. Immunol.
50:629–634.
3. Berendt, M. J., and North, R. J., 1980, T-cell-mediated suppression of antitumor immunity. An explanation for progressive growth of an immunogenic tumor, J. Exp. Med.
151:69–80.
4. Berendt, M. J., North, R. J., and Kirstein, D. P., 1978, The immunological basis of endotoxicinduced tumor regression. Requirement for T cell mediated immunity, J. Exp. Med.
148:1550–1559.
5. Berenson, J. R., Einstein, A. B., and Fefer, A., 1975, Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: Requirement for T cells, J. Immunol.
115:234–238.